COLLEEN FRADY: Open Payments
NPI 1013548296 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 24 payments from 12 companies in 2025. Trend: 2023 $97 · 2024 $20 · 2025 $490
Food & beverage: $490
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $96 |
| UCB, Inc. | 2 | $57 |
| SK Life Science, Inc. | 2 | $52 |
| Eisai Inc. | 2 | $52 |
| Neurelis, Inc. | 2 | $39 |
| ABBVIE INC. | 2 | $38 |
| Alexion Pharmaceuticals, Inc. | 2 | $37 |
| Lundbeck LLC | 2 | $37 |
| PFIZER INC. | 2 | $29 |
| GE HEALTHCARE | 1 | $23 |
Products named: KESIMPTA, Fintepla, Leqembi, VALTOCO, UBRELVY, ULTOMIRIS, NURTEC ODT, VYEPTI.
Industry payments across LA — which companies pay providers there.
